JMI White Paper now available through the World Anti-Microbial Congress
JMI provided a white paper, “Why Selecting the Appropriate Bacterial and Fungal Isolates in Your Drug Development Program Matters,” for the World Anti-Microbial Congress, held on October 8-9, 2020. The white paper was written by JMI Principal Scientist Leonard Duncan and CEO Andrew Fuhrmeister.
JMI White Paper now available through the World Anti-Microbial Congress
